(HON) Honeywell International - Overview
Stock: Avionics, Sensors, Automation, Catalysts, Software
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.16% |
| Yield on Cost 5y | 2.53% |
| Yield CAGR 5y | 5.40% |
| Payout Consistency | 96.2% |
| Payout Ratio | 33.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.7% |
| Relative Tail Risk | -6.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.80 |
| Alpha | 3.08 |
| Character TTM | |
|---|---|
| Beta | 0.788 |
| Beta Downside | 0.909 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.10% |
| CAGR/Max DD | 0.48 |
Description: HON Honeywell International January 27, 2026
Honeywell International Inc. (NASDAQ: HON) operates four core divisions: Aerospace Technologies, delivering power units, avionics, and related services; Industrial Automation, supplying control systems, sensors, and analytics for manufacturing; Building Automation, offering software, energy-management hardware, and security solutions; and Energy & Sustainability Solutions, focused on fuels, carbon-management technologies, and specialty materials. The company serves global customers across aerospace, industrial, commercial-building, and energy markets from its headquarters in Charlotte, North Carolina.
Key recent metrics (FY 2025): revenue $36.8 billion, operating margin 15.2%, free cash flow $5.2 billion, and a 12% YoY increase in aerospace order backlog, reflecting robust demand for commercial-airline retrofits. The industrial automation segment is benefitting from a projected 6% CAGR in global factory-automation spend (2024-2029), while building-automation revenue grew 8% YoY, driven by stricter ESG and energy-efficiency regulations in Europe and the U.S. In the Energy & Sustainability segment, carbon-capture equipment orders rose 14% as governments expand carbon-pricing schemes, supporting a longer-term upside for Honeywell’s catalyst and adsorbent portfolio.
For a deeper quantitative breakdown, see the ValueRay analysis of HON.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 5.14b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.72 > 1.0 |
| NWC/Revenue: 18.37% < 20% (prev 17.28%; Δ 1.09% < -1%) |
| CFO/TA 0.09 > 3% & CFO 6.38b > Net Income 5.14b |
| Net Debt (20.55b) to EBITDA (9.48b): 2.17 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (638.6m) vs 12m ago -2.47% < -2% |
| Gross Margin: 36.93% > 18% (prev 0.38%; Δ 3654 % > 0.5%) |
| Asset Turnover: 54.03% > 50% (prev 51.19%; Δ 2.84% > 0%) |
| Interest Coverage Ratio: 5.90 > 6 (EBITDA TTM 9.48b / Interest Expense TTM 1.35b) |
Altman Z'' 4.00
| A: 0.10 (Total Current Assets 30.83b - Total Current Liabilities 23.42b) / Total Assets 74.11b |
| B: 0.72 (Retained Earnings 53.50b / Total Assets 74.11b) |
| C: 0.11 (EBIT TTM 7.94b / Avg Total Assets 74.66b) |
| D: 0.26 (Book Value of Equity 15.44b / Total Liabilities 58.67b) |
| Altman-Z'' Score: 4.00 = AA |
Beneish M -3.06
| DSRI: 0.93 (Receivables 7.62b/7.82b, Revenue 40.34b/38.50b) |
| GMI: 1.04 (GM 36.93% / 38.34%) |
| AQI: 0.95 (AQ_t 0.52 / AQ_t-1 0.55) |
| SGI: 1.05 (Revenue 40.34b / 38.50b) |
| TATA: -0.02 (NI 5.14b - CFO 6.38b) / TA 74.11b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of HON shares?
Over the past week, the price has changed by +4.77%, over one month by +16.32%, over three months by +22.41% and over the past year by +23.22%.
Is HON a buy, sell or hold?
- StrongBuy: 11
- Buy: 2
- Hold: 13
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 239.5 | 0.5% |
| Analysts Target Price | 239.5 | 0.5% |
| ValueRay Target Price | 254.9 | 6.9% |
HON Fundamental Data Overview January 31, 2026
P/E Forward = 21.1416
P/S = 4.0948
P/B = 9.344
P/EG = 2.0946
Revenue TTM = 40.34b USD
EBIT TTM = 7.94b USD
EBITDA TTM = 9.48b USD
Long Term Debt = 30.09b USD (from longTermDebt, two quarters ago)
Short Term Debt = 5.89b USD (from shortTermDebt, last quarter)
Debt = 33.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.55b USD (from netDebt column, last quarter)
Enterprise Value = 173.42b USD (153.32b + Debt 33.03b - CCE 12.93b)
Interest Coverage Ratio = 5.90 (Ebit TTM 7.94b / Interest Expense TTM 1.35b)
EV/FCF = 32.16x (Enterprise Value 173.42b / FCF TTM 5.39b)
FCF Yield = 3.11% (FCF TTM 5.39b / Enterprise Value 173.42b)
FCF Margin = 13.37% (FCF TTM 5.39b / Revenue TTM 40.34b)
Net Margin = 12.74% (Net Income TTM 5.14b / Revenue TTM 40.34b)
Gross Margin = 36.93% ((Revenue TTM 40.34b - Cost of Revenue TTM 25.44b) / Revenue TTM)
Gross Margin QoQ = 35.56% (prev 34.08%)
Tobins Q-Ratio = 2.34 (Enterprise Value 173.42b / Total Assets 74.11b)
Interest Expense / Debt = 1.14% (Interest Expense 376.0m / Debt 33.03b)
Taxrate = 17.98% (1.07b / 5.95b)
NOPAT = 6.52b (EBIT 7.94b * (1 - 17.98%))
Current Ratio = 1.32 (Total Current Assets 30.83b / Total Current Liabilities 23.42b)
Debt / Equity = 2.14 (Debt 33.03b / totalStockholderEquity, last quarter 15.44b)
Debt / EBITDA = 2.17 (Net Debt 20.55b / EBITDA 9.48b)
Debt / FCF = 3.81 (Net Debt 20.55b / FCF TTM 5.39b)
Total Stockholder Equity = 16.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.88% (Net Income 5.14b / Total Assets 74.11b)
RoE = 31.25% (Net Income TTM 5.14b / Total Stockholder Equity 16.45b)
RoCE = 17.07% (EBIT 7.94b / Capital Employed (Equity 16.45b + L.T.Debt 30.09b))
RoIC = 12.47% (NOPAT 6.52b / Invested Capital 52.24b)
WACC = 7.42% (E(153.32b)/V(186.35b) * Re(8.82%) + D(33.03b)/V(186.35b) * Rd(1.14%) * (1-Tc(0.18)))
Discount Rate = 8.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.70%
[DCF Debug] Terminal Value 81.30% ; FCFF base≈5.21b ; Y1≈5.64b ; Y5≈7.00b
Fair Price DCF = 183.2 (EV 136.88b - Net Debt 20.55b = Equity 116.33b / Shares 634.9m; r=7.42% [WACC]; 5y FCF grow 9.35% → 2.90% )
EPS Correlation: 81.20 | EPS CAGR: 8.46% | SUE: 0.51 | # QB: 0
Revenue Correlation: 90.69 | Revenue CAGR: 4.16% | SUE: -0.81 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.34 | Chg30d=-0.056 | Revisions Net=-5 | Analysts=13
EPS current Year (2026-12-31): EPS=10.50 | Chg30d=-0.041 | Revisions Net=-7 | Growth EPS=+7.4% | Growth Revenue=+5.8%
EPS next Year (2027-12-31): EPS=11.49 | Chg30d=-0.070 | Revisions Net=-5 | Growth EPS=+9.5% | Growth Revenue=+5.6%